The ABL90 FLEX point-of-care (POC) analyzer is now available with optional wireless capability, enhancing the device’s utility, portability and flexibility for clinical applications, according to manufacturer Radiometer America.
Patients with COPD who participated in any level of moderate to vigorous physical activity had a lower risk of hospital readmission within 30 days, compared to those who were inactive, according to a Kaiser Permanente study.
The FDA has approved Ragwitek, a sublingual allergen extract to treat short ragweed pollen induced allergic rhinitis (hay fever) in adults 18 years through 65 years of age.
RT Magazine will host a free webinar presentation on COPD readmissions on Monday, April 28 at 2:00pmET (11:00amPT) sponsored by Nonin Medical. Four COPD experts will present successful multidisciplinary strategies for reducing and preventing unnecessary COPD readmissions. Sign up today!
Researchers have sequenced the entire genome and all the RNA products of the most important pathogenic lineage of Cryptococcus neoformans, a strain called H99 — a fungus responsible for a million cases of pneumonia and meningitis every year.
Low-risk Medicare patients entering home care who received medication therapy management by phone were three times less likely to be hospitalized within the next two months, while those at greater risk saw no benefit.
An article recently published in the International Journal of Surgery shows the potential applications for Google Glass in the surgical setting, particularly in relation to training.
The discovery could lead to new therapies and better diagnostics, resulting in fewer hospitalizations of children with respiratory syncytial virus, the most common cause of admission in children under the age of 1.
The drug sirolimus slows progression of a severe and progressive lung disease called lymphangioleiomyomatosis (LAM), but the drug can cause fatal complications for those patients needing lung transplant.
Spacelabs Healthcare is recalling the Arkon Anesthesia System with Version 2.0 Software due to a software defect that may cause serious adverse health consequences, including hypoxemia and death, according to an FDA announcement.